China Resources Pharmaceutical Group Ltd.
3320Pharmaceuticals
HK$4.64+3.11%As of Oct 30vs prior close
- Market cap
- $3.7B
- P/E (TTM)
- 5.9×
- P/E (FY1)
- 5.0×
- From 52W high
- −28.69%
- EPS (TTM)
- CN¥0.64
- Revenue (LTM)
- CN¥272.2B
- Net margin
- 1.53%
Nomior Score
53
Patient ValueTop 42% of the scored universe
Growth46
Quality47
Value82
Momentum32
Resilience56
Growth
+7.30%revenue a year over 3 fiscal years
YE22 CN¥218.2BLTM CN¥272.2B
Connections
Revenue to profitYE25
2% of revenue became net profit.